Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.

Oncotarget

Volumn 1, Issue 7, 2010, Pages 515-529

  Mulder, Karen ^a   Koski, Sheryl ^b   Scarfe, Andrew ^b   Chu, Quincy ^b   King, Karen ^b   Spratlin, Jennifer ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; NEW DRUG; PROTEIN KINASE INHIBITOR;

ADENOCARCINOMA; BILIARY TRACT TUMOR; BIOLOGICAL MODEL; CARCINOMA; DISEASE COURSE; EVALUATION; GASTROINTESTINAL TUMOR; HUMAN; LIVER TUMOR; METHODOLOGY; ONCOLOGY; PANCREAS TUMOR; PATHOLOGY; REVIEW;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; BILIARY TRACT NEOPLASMS; CARCINOMA; DISEASE PROGRESSION; DRUGS, INVESTIGATIONAL; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; PROTEIN KINASE INHIBITORS;

EID: 79958016793     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.187     Document Type: Review

References (0)